covid 19 News and Research

RSS

Anti-Omicron antibodies are induced by hypermutation with ancestral BNT162b2 COVID vaccine

Scientists from the Republic of Korea have analyzed B-cell receptor repertoires induced by an mRNA-based coronavirus disease 2019 (COVID-19) vaccine and found that somatic hypermutations in B-cell receptor heavy chain are responsible for broadening its specificity for unexposed antigens.

16 Mar 2023

Examining SARS-CoV-2 origin theories

A recent study published in the Journal of Virology summarized the evidence on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) origin hypotheses.

16 Mar 2023

Monoclonal antibody-based blocking ELISA for SARS-CoV-2 detection in animals

In a recent study posted to the bioRxiv* preprint server, researchers in the United States described a blocking enzyme-linked immunosorbent assay (ELISA) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure in animals.

16 Mar 2023

A novel pan-sarbecovirus vaccine candidate neutralizes Omicron BQ.1.1 and XBB subvariants

Researchers provide evidence that a novel vaccine candidate robustly neutralized SARS-CoV-2 Omicron subvariants BQ.1.1 and XBB.

16 Mar 2023

Creating more effective and safe treatments for COVID-19

When approaching a task, members of a team need to work in synergy. Nothing can be accomplished if you're pulling in different directions.

16 Mar 2023

Automata LINQ; Unlocking open, integrated lab automation

In this interview, we speak to Mostafa ElSayed, CEO of Automata, about their new, accessible, lab automation platform Automata Labs and its benefits for scientific research.

From Automata 16 Mar 2023

Is there an association between COVID-19 and an increased incidence of temporomandibular disorders?

Researchers assessed the association between COVID-19-related stress, depression, anxiety, and temporomandibular disorders from childhood to adulthood.

16 Mar 2023

Global maternal Strep B immunization program may save millions of dollars in healthcare costs

A global maternal immunization program for group B Streptococcus - Strep B - would save millions of dollars in healthcare costs by reducing death and disability, a team led by researchers from the London School of Hygiene & Tropical Medicine has found.

16 Mar 2023

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the Department of Biochemical Engineering that analyzed the interaction between the PaxlovidTM ingredients that are used as COVID-19 treatment and other prescription drugs was published as a thesis.

16 Mar 2023

Study: Black Americans lost trust in cancer information given out by the government during the pandemic

Trust in information given out by the government on cancer fell sharply among the Black population, by almost half, during the COVID-19 pandemic findings of a national US study have shown.

16 Mar 2023

Study provides strong support for AAV.NT-3 gene therapy in the management of sarcopenia

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 5, entitled, "AAV1.NT-3 gene therapy prevents age-related sarcopenia."

16 Mar 2023

Bormioli Pharma announces robust growth in its North American business in 2022

Bormioli Pharma, a global leader partnering with customers to provide comprehensive packaging solutions for injectable drugs, today announced robust growth in its North American business in 2022, with sales increasing more than 40% year-over-year.

16 Mar 2023

Using probiotics to treat depression

Researchers discuss whether probiotics could be used as supplementary or primary therapy to manage major depressive disorder.

15 Mar 2023

Johns Hopkins’ ARISE program may increase the odds of home discharge for hospitalized COVID-19 patients

The Acute Hospital Rehabilitation Intensive Service (ARISE) program, developed in 2020 by the Johns Hopkins Department of Physical Medicine and Rehabilitation (PM&R), may increase the chances of patients hospitalized with COVID-19 getting discharged to their home rather than to a rehabilitation facility that provides post-hospitalization care services.

15 Mar 2023

Effectiveness of SPARK Resilience program during COVID-19 pandemic

Resilience and well-being in difficult times can be developed via online interventions in the workplace. An international team of researchers from France, the UK and Russia (with the participation of researchers from the HSE International Laboratory of Positive Psychology of Personality and Motivation) studied the effectiveness of SPARK Resilience, a programme for developing resilience, at the beginning of the COVID-19 pandemic.

15 Mar 2023

covid 19 News and Research

Anti-Omicron antibodies are induced by hypermutation with ancestral BNT162b2 COVID vaccine

Examining SARS-CoV-2 origin theories

Monoclonal antibody-based blocking ELISA for SARS-CoV-2 detection in animals

A novel pan-sarbecovirus vaccine candidate neutralizes Omicron BQ.1.1 and XBB subvariants

Creating more effective and safe treatments for COVID-19

Automata LINQ; Unlocking open, integrated lab automation

Is there an association between COVID-19 and an increased incidence of temporomandibular disorders?

Global maternal Strep B immunization program may save millions of dollars in healthcare costs

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

Study: Black Americans lost trust in cancer information given out by the government during the pandemic

Study provides strong support for AAV.NT-3 gene therapy in the management of sarcopenia

Bormioli Pharma announces robust growth in its North American business in 2022

Using probiotics to treat depression

Johns Hopkins’ ARISE program may increase the odds of home discharge for hospitalized COVID-19 patients

Effectiveness of SPARK Resilience program during COVID-19 pandemic

Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients

Children's immunity to COVID-19 provided by common colds

New CDC opioid guidelines: Too little, too late for chronic pain patients?

Bormioli Pharma North America sales grew by more than 40% in 2022

Study identifies link between oral and gut microbiomes and depression

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News